TIS
Click for more information
0.00% 0.0¢ tissue therapies limited

Ann: Appendix 4C - quarterly , page-4

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
  1. advisor71
    878 Posts.
    lightbulb Created with Sketch. 2
    clock Created with Sketch.
    19/04/12
    09:41
    Post #: 10003117
    IMO they have been building up the inventory for release of the product on the market. I also believe that the revenue will be enough from the sales to negate any need for any CR. My thoughts only but I have great confidence in the product and money is in the bank as far as I am concerned. DYOR
    TIS Price at posting: 45.0¢ Sentiment: LT Buy Disclosure: Held
    Likes Created with Sketch. 8  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Bitcoin hits all-time high as markets predict Trump victory: Join Discussion here!
right-arrow Created with Sketch.
NEWS Domino's Don Meij steps down after 22 years as CEO
right-arrow Created with Sketch.
RMX Red Mountain Mining (ASX:RMX) announces Bonanza Grade Gold Results at Flicka Lake
right-arrow Created with Sketch.
NEWS PYC Therapeutics moves into final stage of child blindness study
right-arrow Created with Sketch.
NEWS Imugene kicks off Australian trial for blood cancer treatment
right-arrow Created with Sketch.
EQN Equinox Resources reports outstanding naturally occurring antimony grade at Alturas Project
right-arrow Created with Sketch.
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.